BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3039352)

  • 1. Abelson virus transformation of an interleukin 2-dependent antigen-specific T-cell line.
    Cook WD; Fazekas de St Groth B; Miller JF; MacDonald HR; Gabathuler R
    Mol Cell Biol; 1987 Jul; 7(7):2631-5. PubMed ID: 3039352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Friend murine leukemia virus-immortalized myeloid cells are converted into tumorigenic cell lines by Abelson leukemia virus.
    Oliff A; Agranovsky O; McKinney MD; Murty VV; Bauchwitz R
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3306-10. PubMed ID: 2987918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Abelson murine leukemia virus on granulocytic differentiation and interleukin-3 dependence of a murine progenitor cell line.
    Rovera G; Valtieri M; Mavilio F; Reddy EP
    Oncogene; 1987 Mar; 1(1):29-35. PubMed ID: 2449644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
    Green PL; Kaehler DA; McKearn J; Risser R
    Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism.
    Pierce JH; Di Fiore PP; Aaronson SA; Potter M; Pumphrey J; Scott A; Ihle JN
    Cell; 1985 Jul; 41(3):685-93. PubMed ID: 2988783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of multiple hemopoietic growth factor genes in Abelson virus-transformed myeloid cells.
    Humphries RK; Abraham S; Krystal G; Lansdorp P; Lemoine F; Eaves CJ
    Exp Hematol; 1988 Oct; 16(9):774-81. PubMed ID: 2844575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular RNA homologous to the Abelson murine leukemia virus transforming gene: expression and relationship to the viral sequence.
    Wang JY; Baltimore D
    Mol Cell Biol; 1983 May; 3(5):773-9. PubMed ID: 6306446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation.
    Prywes R; Foulkes JG; Rosenberg N; Baltimore D
    Cell; 1983 Sep; 34(2):569-79. PubMed ID: 6193890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and function of the Abelson murine leukemia virus transforming gene.
    Wang JY; Prywes R; Baltimore D
    Prog Clin Biol Res; 1983; 119():57-63. PubMed ID: 6306691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.
    Reddy EP; Smith MJ; Srinivasan A
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3623-7. PubMed ID: 6304726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of v-abl oncogene induces monocytic differentiation of an IL-3-dependent myeloid progenitor cell line.
    Keller JR; Ruscetti SK; Ruscetti FW
    Oncogene; 1990 Apr; 5(4):549-55. PubMed ID: 2158039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line.
    Mathey-Prevot B; Nabel G; Palacios R; Baltimore D
    Mol Cell Biol; 1986 Nov; 6(11):4133-5. PubMed ID: 3025637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral oncogene expression during differentiation of Abelson virus-infected murine promonocytic leukemia cells.
    Hines DL
    Cancer Res; 1988 Apr; 48(7):1702-7. PubMed ID: 2832050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible dependence on growth factor interleukin-3 in myeloid cells expressing temperature sensitive v-abl oncogene.
    Kipreos ET; Wang JY
    Oncogene Res; 1988 Feb; 2(3):277-84. PubMed ID: 3259302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.
    Rees-Jones RW; Goff SP
    J Virol; 1988 Mar; 62(3):978-86. PubMed ID: 2828693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of T-lymphoid cells by Abelson murine leukemia virus.
    Scott ML; Davis MM; Feinberg MB
    J Virol; 1986 Aug; 59(2):434-43. PubMed ID: 2874233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct helper virus requirements for Abelson murine leukemia virus-induced pre-B- and T-cell lymphomas.
    Poirier Y; Jolicoeur P
    J Virol; 1989 May; 63(5):2088-98. PubMed ID: 2539505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The minimum transforming region of v-abl is the segment encoding protein-tyrosine kinase.
    Prywes R; Foulkes JG; Baltimore D
    J Virol; 1985 Apr; 54(1):114-22. PubMed ID: 2983108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal assignment of the endogenous proto-oncogene C-abl.
    Goff SP; D'Eustachio P; Ruddle FH; Baltimore D
    Science; 1982 Dec; 218(4579):1317-9. PubMed ID: 6293057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abelson murine leukemia virus mutants with alterations in the virus-specific P120 molecule.
    Rosenberg N; Witte ON
    J Virol; 1980 Jan; 33(1):340-8. PubMed ID: 6245237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.